Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Stopped This was a follow-on study to Biomed 777-CLP-029 which did not meet superiority endpoint

Conditions

• Breast Neoplasms
• Neoplasms, Hormone-Dependent

Interventions

• DRUG: Atamestane
• DRUG: toremifene
• DRUG: letrozole

Sponsor

Intarcia Therapeutics